Please login to read the full article.
Scrip Regulatory Affairs
NICE in UK finalises guidance on widened access to Alzheimer's drugs
06 April 2011
Francesca Bruce
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- UK PIP report highlights need to improve adverse incident reporting; registries urged
- US FDA action on drug shortages yields results, agency improves user fee goals
- Could another US biosimilars fight be brewing?
- US court verdict on insurance finds in favour of saving remainder of healthcare reform act
Other Informa News
ANALYSIS
Other Informa Analysis
EDITORIALS
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
